STADA Arzneimittel Names Peter Goldschmidt CEO - Quick Facts

Shutterstock photo

(RTTNews.com) - STADA Arzneimittel AG (STDAY.PK, STDAF.PK) announced that Peter Goldschmidt succeeded Claudio Albrecht as CEO, effective September 1, 2018. Goldschmidt was most recently President of SANDOZ US, the global generics division of Novartis, and Head of North America.

Previously, Peter Goldschmidt was the Global Executive Member for Central and Eastern Europe for Sandoz.

Read the original article on RTTNews (http://www.rttnews.com/2931343/stada-arzneimittel-names-peter-goldschmidt-ceo-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

This article appears in: World Markets , Stocks , Economy
Referenced Symbols: NVS ,

More from RTT News


See All RTT news

Research Brokers before you trade

Want to trade FX?